Article
Genome editing with natural and engineered CjCas9 orthologs.
Molecular therapy : the journal of the American Society of Gene Therapy - 5 Apr 2023
Gao Siqi, Wang Yao, Qi Tao, Wei Jingjing, Hu Ziying, Liu Jingtong, Sun Shuna, Liu Huihui, Wang Yongming
Abstract excerpt
CjCas9 is one of the smallest CRISPR-associated (Cas9) nucleases for mammalian genome editing. However, it requires a long N4RYAC (R = A or G; Y = C or T) protospacer-adjacent motif (PAM), limiting its DNA targeting scope. In this study, we investigated the PAMs of three CjCas9 orthologs, including Hsp1Cas9, Hsp2Cas9, and CcuCas9, by performing a GFP-activation assay. Interestingly, Hsp1Cas9 and CcuCas9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
